Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury

Abstract This study examined the prevalence of growth hormone deficiency (GHD) in patients with traumatic brain injury (TBI) during the post-acute phase of recovery and whether GHD was associated with increased disability, decreased independence, and depression. A secondary objective was to determine the accuracy of insulin-like growth factor-1 (IGF-1) levels in predicting GHD in patients with TBI. Anterior pituitary function was assessed in 235 adult patients with TBI through evaluation of fasting morning hormone levels. GH levels were assessed through provocative testing, specifically the glucagon stimulation test. GHD was diagnosed in a significant number of patients, with 45% falling into the severe GHD (≤3 μg/L) category. IGF-1 levels were not predictive of GHD. Patients with GHD were more disabled and less independent compared with those patients who were not GHD. Those patients with more severe GHD also showed decreased levels of cortisol and testosterone. Symptoms of depression were also more prevalent in this group. In addition, patients with severe GHD had delayed admission to post-acute rehabilitation. This study confirms the high prevalence of GHD in patients with TBI and the necessity to monitor clinical symptoms and perform provocative testing to definitively diagnose GHD.

[1]  Dams-O'ConnorKristen,et al.  The Impact of Previous Traumatic Brain Injury on Health and Functioning: A TRACK-TBI Study , 2013 .

[2]  E. Rosario,et al.  Hypothalamic-Pituitary Dysfunction Following Traumatic Brain Injury Affects Functional Improvement During Acute Inpatient Rehabilitation , 2013, The Journal of head trauma rehabilitation.

[3]  J. Devesa,et al.  Role of growth hormone (GH) in the treatment on neural diseases: From neuroprotection to neural repair , 2013, Neuroscience Research.

[4]  Pratik Mukherjee,et al.  The impact of previous traumatic brain injury on health and functioning: a TRACK-TBI study. , 2013, Journal of neurotrauma.

[5]  B. Masel,et al.  Serum IGF‐1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing , 2011, Clinical endocrinology.

[6]  J. Devesa,et al.  Hormona de crecimiento: acciones y aplicaciones preventivas y terapéuticas , 2010 .

[7]  B. Masel,et al.  Effect of growth hormone replacement therapy on cognition after traumatic brain injury. , 2010, Journal of neurotrauma.

[8]  B. Masel,et al.  Traumatic brain injury: a disease process, not an event. , 2010, Journal of neurotrauma.

[9]  D. Åberg Role of the growth hormone/insulin-like growth factor 1 axis in neurogenesis. , 2010, Endocrine development.

[10]  L. Chiovato,et al.  Testing growth hormone deficiency in adults. , 2010, Frontiers of hormone research.

[11]  M. Molitch,et al.  Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? , 2009, The Journal of clinical endocrinology and metabolism.

[12]  L. Brenner,et al.  Hypogonadism on admission to acute rehabilitation is correlated with lower functional status at admission and discharge , 2009, Brain injury.

[13]  F. Casanueva,et al.  New Guidelines for the Diagnosis of Growth Hormone Deficiency in Adults , 2009, Hormone Research in Paediatrics.

[14]  D. McArthur,et al.  CHRONIC HYPOPITUITARISM AFTER TRAUMATIC BRAIN INJURY: RISK ASSESSMENT AND RELATIONSHIP TO OUTCOME , 2008, Neurosurgery.

[15]  T. Miller,et al.  Incidence of Long‐term Disability Following Traumatic Brain Injury Hospitalization, United States, 2003 , 2008, The Journal of head trauma rehabilitation.

[16]  D. Arciniegas,et al.  The neuroendocrine effects of traumatic brain injury. , 2007, The Journal of neuropsychiatry and clinical neurosciences.

[17]  M. Kosteljanetz,et al.  Prevalence and predictive factors of post‐traumatic hypopituitarism , 2007, Clinical endocrinology.

[18]  J. Leon-Carrion,et al.  Cognitive deterioration due to GH deficiency in patients with traumatic brain injury: A preliminary report , 2007, Brain injury.

[19]  D. Burke,et al.  The role of serum testosterone and TBI in the in-patient rehabilitation setting , 2007, Brain injury.

[20]  K. Ho,et al.  Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II : a statement of the GH Research Society in association with the European Society for Pediatric , 2007 .

[21]  F. Casanueva,et al.  High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  H. Schneider,et al.  Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. , 2006, European journal of endocrinology.

[23]  M. Forsting,et al.  Hypopituitarism following severe traumatic brain injury. , 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[24]  J. Langlois,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths , 2006 .

[25]  S. Cannavò,et al.  Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  E. Elovic,et al.  Consensus guidelines on screening for hypopituitarism following traumatic brain injury , 2005, Brain injury.

[27]  F. Casanueva,et al.  Prevalence of hypopituitarism and growth hormone deficiency in adults long‐term after severe traumatic brain injury , 2005, Clinical endocrinology.

[28]  M. Bondanelli,et al.  Hypopituitarism after traumatic brain injury. , 2005, European journal of endocrinology.

[29]  J. Phillips,et al.  The natural history of post-traumatic hypopituitarism: implications for assessment and treatment. , 2005, The American journal of medicine.

[30]  D. Pavlović,et al.  Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress , 2004, Journal of endocrinological investigation.

[31]  J. Phillips,et al.  Anterior pituitary dysfunction in survivors of traumatic brain injury. , 2004, The Journal of clinical endocrinology and metabolism.

[32]  M. Farneti,et al.  Occurrence of pituitary dysfunction following traumatic brain injury. , 2004, Journal of neurotrauma.

[33]  Ali Iranmanesh,et al.  Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  P. Freda Pitfalls in the Biochemical Assessment of Acromegaly , 2004, Pituitary.

[35]  S. Shalet,et al.  Determinants of IGF‐I status in a large cohort of growth hormone‐deficient (GHD) subjects: the role of timing of onset of GHD , 2003, Clinical endocrinology.

[36]  M. Vaisman,et al.  Glucagon stimulation test for the diagnosis of GH deficiency in adults , 2003, Journal of endocrinological investigation.

[37]  D. Cook,et al.  Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. , 2002, The Journal of clinical endocrinology and metabolism.

[38]  J. Mesa,et al.  Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults , 2002, Clinical endocrinology.

[39]  B. Masel,et al.  Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. , 2001, The Journal of clinical endocrinology and metabolism.

[40]  M. Ashley,et al.  Validation of an independent living scale for post-acute rehabilitation applications. , 2001, Brain injury.

[41]  R. Swerdloff,et al.  Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. , 2000, Journal of neurosurgery.

[42]  M. Lezak,et al.  Refining a Measure of Brain Injury Sequelae to Predict Postacute Rehabilitation Outcome: Rating Scale Analysis of the Mayo‐Portland Adaptability Inventory , 2000, The Journal of head trauma rehabilitation.

[43]  S. Wardlaw,et al.  Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.

[44]  P. Carroll,et al.  Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review , 1998 .

[45]  D. Krych,et al.  Long-term follow-up of post-acute traumatic brain injury rehabilitation: a statistical analysis to test for stability and predictability of outcome. , 1997, Brain injury.

[46]  A. Grossman,et al.  An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year , 1994, Clinical endocrinology.

[47]  Mary Lou Coad,et al.  THE COMMUNITY INTEGRATION QUESTIONNAIRE: A Comparative Examination , 1994, American journal of physical medicine & rehabilitation.

[48]  P. Sönksen,et al.  Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. , 1990, Hormone research.

[49]  M Rappaport,et al.  Disability rating scale for severe head trauma: coma to community. , 1982, Archives of physical medicine and rehabilitation.